03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
On June 7, 2019, in Altera Corp. v. Commissioner, a reconstituted panel of the U.S. Court of Appeals...
Read More >
Does a seller’s breach of representations and warranties in a merger and acquisition (M&A) transact...
Read More >
It’s 2019 and lets face facts: behavior that might have been tolerated in the 1970s and 1980s aren’...
Read More >
New Mexico has been making waves with several noteworthy labor and employment developments. This Lig...
Read More >
I’ve been an ERISA attorney for 21 years, so like the J.K. Simmons character in the Farmers Insuran...
Read More >
On October 8, 2020, Hank Harris, the director of Ward and Smith Business Consulting and a senior cha...
Read More >